COVID-19 Products Still Vulnerable To Falsification & Diversion
High demand for genuine COVID-19 products, together with related product shortages, has fueled the proliferation of falsified, substandard and counterfeit vaccines, medicines and diagnostic tests.
You may also be interested in...
The lack of availability of coronavirus vaccines in many less well off parts of the world is an open invitation to criminals seeking to sell falsified or substandard versions. Many instances of vaccine theft and diversion have also been found.
New, more flexible regulatory approaches will be needed to deal with the integrated therapies coming through company pipelines, and the European Medicines Agency should play a “key orchestrating role” in smoothing the way, says Sabine Atzor, Roche’s head of EU regulatory policies.
If successful, a new Swedish model for reimbursing antibiotics that involves guaranteed minimum annual revenues for companies, could be tested on other kinds of products.